<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04330222</url>
  </required_header>
  <id_info>
    <org_study_id>A095132</org_study_id>
    <nct_id>NCT04330222</nct_id>
  </id_info>
  <brief_title>Cambridge 7 Tesla Cerebral Small Vessel Disease Study</brief_title>
  <acronym>CamSVD</acronym>
  <official_title>Imaging the Arterial Pathology in Cerebral Small Vessel Disease Using 7 Tesla Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wolfson Brain Imaging Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cambridge</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CamSVD is jointly sponsored by the University of Cambridge and Cambridge University Hospitals
      NHS Foundation Trust.

      We aim to explore and understand the underlying arterial pathology in Cerebral Small Vessel
      Disease (SVD) using ultra-high-field 7 Tesla MRI. We will optimise 7T Time-of-Flight MR
      angiography, blood suppressed MR sequence and phase-contrast (PC) MR angiography for
      visualization of perforating lenticulostriate arteries. This optimised sequences will be used
      to determine the range of arterial pathologies seen in individuals presenting with lacunar
      strokes. The pathologies of the perforating lenticulostriate arteries will be correlated with
      conventional clinical risk factors, cognition and radiological markers of SVD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">January 12, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 12, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Range and pattern of pathology seen in the perforating arteries like presence or absence of focal atheroma and narrowing</measure>
    <time_frame>March 2020-</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in morphology of perforating arteries between SVD patients and healthy volunteers</measure>
    <time_frame>March 2020-</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of morphology of perforating arteries with cardiovascular risk factors and radiological markers of SVD</measure>
    <time_frame>March 2020-</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Cerebral Small Vessel Diseases</condition>
  <condition>Cerebral Small Vessel Ischemic Disease</condition>
  <condition>Lacunar Stroke</condition>
  <arm_group>
    <arm_group_label>Patients with lacunar stroke due to SVD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy stroke free volunteers</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>7 Tesla Magnetic Resonance Imaging</intervention_name>
    <description>Diagnostic Imaging</description>
    <arm_group_label>Healthy stroke free volunteers</arm_group_label>
    <arm_group_label>Patients with lacunar stroke due to SVD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brief Memory and Executive Test</intervention_name>
    <description>Cognitive Assessment</description>
    <arm_group_label>Patients with lacunar stroke due to SVD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Lacunar Strokes due to Cerebral Small Vessel Disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Symptomatic lacunar stroke with corresponding lacunar infarct on MRI

        Exclusion Criteria:

          1. Unable/unwilling to consent;

          2. Age&lt;18;

          3. Stroke aetiology due to cardio-embolism or large vessel disease;

          4. Lacunar infarcts &gt;1.5cm;

          5. Severe stroke (NIHSS score â‰¥16);

          6. Evidence of cortical infarct of any size;

          7. Other major neurological diseases;

          8. Severe systemic diseases such as heart failure, liver failure and kidney failure or
             any illness in the judgement of the investigator that could affect participation in
             the study;

          9. MRI contraindications e.g. metal objects in or on the body, claustrophobia, pregnancy,
             known allergy to gadolinium containing contrast agent, impaired renal function with
             estimated glomerular filtration rate (eGFR) &lt;59ml/min/1.73m2.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugh S Markus, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge Department of Clinical Neurosciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher Osuafor, MRCPI</last_name>
    <phone>01223 274 383</phone>
    <email>co400@cam.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Cambridge</name>
      <address>
        <city>Cambridge</city>
        <zip>CB2 0QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Osuafor, MRCPI</last_name>
      <phone>01223 274 383</phone>
      <email>co400@cam.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Laurence Loubiere, PhD</last_name>
      <phone>01223 217 695</phone>
      <email>lhl31@medschl.cam.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>March 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2020</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cambridge</investigator_affiliation>
    <investigator_full_name>Christopher Osuafor</investigator_full_name>
    <investigator_title>Study Co-ordinator and Co-investigator</investigator_title>
  </responsible_party>
  <keyword>Vascular Cognitive Impairment</keyword>
  <keyword>Vascular Dementia</keyword>
  <keyword>7 Tesla Magnetic Resonance Imagine (7T MRI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Small Vessel Diseases</mesh_term>
    <mesh_term>Stroke, Lacunar</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

